ibutilide

Known as: ibutilide [Chemical/Ingredient], Ibutilidum, N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2017
010203019912017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Sustained atrial fibrillation and atrial flutter during pregnancy are uncommon arrhythmias that can significantly complicate… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVES We sought to test the hypothesis that complex fractionated electrograms (CFAEs) recorded during atrial fibrillation… (More)
  • figure 1
  • table 1
  • figure 6
Is this relevant?
Highly Cited
2001
Highly Cited
2001
CONTEXT Women have a higher incidence of torsades de pointes than men, but it is not known if the risk of drug-induced torsades… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND Atrial fibrillation cannot always be converted to sinus rhythm by transthoracic electrical cardioversion. We examined… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
This study assesses a technique for quantifying the frequency spectrum of atrial fibrillation (AF) using the surface… (More)
Is this relevant?
1998
1998
OBJECTIVE To compare the efficacy and safety of a single dose of ibutilide, a new class III antiarrhythmic drug, with that of DL… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
OBJECTIVES This multicenter study compared the efficacy and safety of ibutilide versus procainamide for conversion of recent… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
BACKGROUND Currently available antiarrhythmic drugs have limited efficacy for acute termination of atrial fibrillation and… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
OBJECTIVES Currently available antiarrhythmic drugs have limited efficacy for short-term, rapid termination of atrial… (More)
Is this relevant?
1995
1995
BACKGROUND Ibutilide is an action potential-prolonging antiarrhythmic currently in clinical trials. The drug shares structural… (More)
Is this relevant?